🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Maryland

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Maryland

8 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan Maryland.

Vil nan Maryland

Tèks ofisyèl etid la (Anglè)

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
  • FMH James M Stockman Cancer Institute, Frederick
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07000084

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

  • Johns Hopkins University, Baltimore
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

  • Johns Hopkins University ( Site 0055), Baltimore
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT06637423

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Johns Hopkins Kimmel Cancer Center, Baltimore
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

  • Johns Hopkins University (Data Collection Only), Baltimore
Ap rekriteFaz 3
Laj 21 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT06929286

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • John Hopkins Hospital, Baltimore
  • Chesapeake Urology Research Associates, Hanover
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

  • Anna Arundel Urology, Annapolis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848

Blue Light Cystoscopy With Cysview® Registry

  • Johns Hopkins Medicine, Baltimore
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.